Methods and compositions of neuregulins for preventing, treating or delaying preserved ejection fraction cardiac failure
View Patent ↗Disclosed are the use of neuregulin proteins in preparing a medicine for preventing, treating or delaying preserved ejection fraction cardiac failure in mammals, and a method for using the medicine. Also provided in the present invention is a method for preventing, treating or delaying preserved ejection fraction cardiac failure in mammals, comprising using the medication containing the neuregulin proteins in a special population having the disease or being at risk of having the disease.
1. A method for treating heart failure with preserved ejection fraction in a mammal, comprising administering neuregulin to the mammal, wherein the neuregulin is NRG-1.
2. The method of claim 1 , wherein the mammal is human.
3. A method for treating heart failure with preserved ejection fraction in a mammal, comprising administering neuregulin to the mammal, wherein the neuregulin comprises the amino acid sequence of SEQ ID NO: 1.
4. The method of claim 3 , wherein the mammal is human.